Risk of bowel cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Intestine, Large Feces Colon Cell Line, Tumor Intestinal Mucosa Neoplastic Stem Cells Breast Intestines Prostate Tumor Cells, Cultured HT29 Cells Rectum HCT116 Cells MCF-7 Cells Ileum

Organisms4

Mice, Nude Bacteria Mice, SCID Mice, Inbred BALB C

Diseases63

Intestinal Neoplasms Intestinal Polyps Colonic Neoplasms Ileal Neoplasms Rectal Neoplasms Inflammatory Bowel Diseases Colorectal Neoplasms Cecal Neoplasms Jejunal Neoplasms Irritable Bowel Syndrome Duodenal Neoplasms Short Bowel Syndrome Adenocarcinoma Adenoma Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Stomach Neoplasms Crohn Disease Colitis, Ulcerative Neoplasm Metastasis Neoplasm Invasiveness Neoplasms Pancreatic Neoplasms Genetic Predisposition to Disease Uterine Cervical Neoplasms Carcinoma Disease Progression Urinary Bladder Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Constipation Neoplasm Recurrence, Local Intestinal Diseases Cell Transformation, Neoplastic Endometrial Neoplasms Esophageal Neoplasms Colonic Diseases Neurogenic Bowel Liver Neoplasms Colitis Head and Neck Neoplasms Neoplasms, Hormone-Dependent Abdominal Pain Mouth Neoplasms Carcinoma, Small Cell Gastrointestinal Neoplasms Neoplasms, Radiation-Induced Neoplasms, Second Primary Bone Neoplasms Genital Neoplasms, Female Neoplasms, Glandular and Epithelial Precancerous Conditions Neovascularization, Pathologic Disease Models, Animal Skin Neoplasms Intestinal Perforation Thyroid Neoplasms Neoplasms, Multiple Primary Mammary Neoplasms, Experimental Diarrhea Pharyngeal Neoplasms

Chemicals and Drugs43

Guaiac Contraceptives, Oral Bile Acids and Salts Cancer Vaccines Neoplasm Proteins Antineoplastic Agents RNA, Messenger Receptors, Estrogen Tumor Markers, Biological Receptor, erbB-2 DNA, Neoplasm Prostate-Specific Antigen RNA, Small Interfering Fluorouracil Tamoxifen Tumor Suppressor Protein p53 Antineoplastic Agents, Hormonal Cisplatin Antigens, Neoplasm Receptors, Progesterone Antineoplastic Agents, Phytogenic Anticarcinogenic Agents Antibodies, Monoclonal Gastrointestinal Agents Paclitaxel Receptor, Epidermal Growth Factor MicroRNAs Tumor Suppressor Proteins Deoxycytidine Antimetabolites, Antineoplastic DNA-Binding Proteins Receptors, Androgen Antibodies, Monoclonal, Humanized Taxoids RNA, Neoplasm BRCA2 Protein Carcinogens Proto-Oncogene Proteins Transcription Factors Androgens Nuclear Proteins Estrogens BRCA1 Protein

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Occult Blood Early Detection of Cancer Colonoscopy Mass Screening Pilot Projects Registries Hormone Replacement Therapy Risk Factors Predictive Value of Tests Incidence Retrospective Studies Survival Analysis Prognosis Prospective Studies Survival Rate Follow-Up Studies Interviews as Topic Antineoplastic Combined Chemotherapy Protocols Risk Reverse Transcriptase Polymerase Chain Reaction Case-Control Studies Gene Expression Profiling Neoplasm Staging Xenograft Model Antitumor Assays Risk Assessment Combined Modality Therapy Odds Ratio Disease-Free Survival Blotting, Western Neoplasm Transplantation Sensitivity and Specificity Questionnaires Chemotherapy, Adjuvant Multivariate Analysis Transplantation, Heterologous Treatment Outcome Clinical Trials as Topic Kaplan-Meier Estimate Oligonucleotide Array Sequence Analysis Mammography Polymerase Chain Reaction SEER Program Tumor Burden Drug Screening Assays, Antitumor Logistic Models Reproducibility of Results Molecular Targeted Therapy Radiotherapy Biopsy Gastrointestinal Transit Transfection Disease Models, Animal Digestive System Surgical Procedures Confidence Intervals Capsule Endoscopy Models, Biological Neoplasm Grading Tissue Array Analysis Immunoenzyme Techniques Drug Administration Schedule Flow Cytometry Colectomy Tomography, X-Ray Computed Palliative Care Enema Gene Knockdown Techniques Immunohistochemistry Mammary Neoplasms, Experimental Mastectomy Genetic Testing

Psychiatry and Psychology2

Attitude to Health Smoking

Phenomena and Processes42

Diet Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Risk Drug Resistance, Neoplasm Mutation Defecation Odds Ratio Sensitivity and Specificity DNA Methylation Genotype Cell Survival Cell Movement Down-Regulation Polymorphism, Genetic Genes, BRCA1 Dose-Response Relationship, Drug Cell Division Cell Proliferation Apoptosis Cell Cycle Promoter Regions, Genetic Up-Regulation Gastrointestinal Transit Cell Growth Processes Transfection RNA Interference Gene Silencing Germ-Line Mutation Genes, Tumor Suppressor Genes, Neoplasm Phenotype Gene Expression Postmenopause Base Sequence Genes, p53 Signal Transduction Gastrointestinal Motility Genes, BRCA2 Time Factors Phosphorylation Alleles

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

Socioeconomic Factors National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science8

Registries Incidence Survival Rate Interviews as Topic Questionnaires SEER Program Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care38

Mass Screening National Health Programs State Medicine Patient Acceptance of Health Care Pilot Projects Registries Risk Factors Attitude to Health Predictive Value of Tests Incidence Socioeconomic Factors Healthcare Disparities Retrospective Studies Survival Analysis Prospective Studies Survival Rate Follow-Up Studies Interviews as Topic Risk National Cancer Institute (U.S.)Case-Control Studies Risk Assessment Age Factors Odds Ratio Disease-Free Survival Sensitivity and Specificity Questionnaires Multivariate Analysis Treatment Outcome Clinical Trials as Topic Kaplan-Meier Estimate SEER Program Logistic Models Reproducibility of Results American Cancer Society Confidence Intervals Palliative Care Genetic Testing

Geographicals7

Australia England North Carolina Asia United States China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Intestinal Neoplasms Occult Blood Intestine, Large Intestinal Polyps Early Detection of Cancer Colonic Neoplasms Ileal Neoplasms Rectal Neoplasms Inflammatory Bowel Diseases Colorectal Neoplasms Colonoscopy Cecal Neoplasms Jejunal Neoplasms Irritable Bowel Syndrome Mass Screening Australia Duodenal Neoplasms Guaiac England National Health Programs State Medicine Patient Acceptance of Health Care Feces Pilot Projects North Carolina Short Bowel Syndrome Contraceptives, Oral Registries Diet Hormone Replacement Therapy Adenocarcinoma Adenoma Risk Factors Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Stomach Neoplasms Attitude to Health Crohn Disease Colitis, Ulcerative Asia Neoplasm Metastasis Neoplasm Invasiveness Predictive Value of Tests Incidence Socioeconomic Factors Neoplasms Bile Acids and Salts Pancreatic Neoplasms Healthcare Disparities Gene Expression Regulation, Neoplastic Mice, Nude Cancer Vaccines Neoplasm Proteins Genetic Predisposition to Disease Retrospective Studies Colon Bacteria Uterine Cervical Neoplasms Survival Analysis Prognosis Prospective Studies Survival Rate Follow-Up Studies Interviews as Topic Carcinoma Antineoplastic Agents Disease Progression Antineoplastic Combined Chemotherapy Protocols Risk Reverse Transcriptase Polymerase Chain Reaction Urinary Bladder Neoplasms Drug Resistance, Neoplasm Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung National Cancer Institute (U.S.)Case-Control Studies Cell Line, Tumor RNA, Messenger Gene Expression Profiling Receptors, Estrogen Mutation Neoplasm Staging Xenograft Model Antitumor Assays Risk Assessment Tumor Markers, Biological Constipation Intestinal Mucosa United States Survivors Neoplasm Recurrence, Local Intestinal Diseases Age Factors Receptor, erbB-2 Defecation Combined Modality Therapy Odds Ratio Disease-Free Survival Blotting, Western

No FAQ available that match "risk of bowel cancer"